High antimüllerian hormone levels are associated with preterm delivery in patients with polycystic ovary syndrome
Antimüllerian hormone (AMH) levels are higher in patients with polycystic ovary syndrome (PCOS). Accumulating evidence indicates that AMH has an impact on the physiology of the female reproductive system.
Source: fertstert.org
High antimüllerian hormone levels are associated with preterm delivery in patients with polycystic ovary syndrome
Published in Embryology and Reproductive Medicine
More from Embryology and Reproductive MedicineMore posts in Embryology and Reproductive Medicine »
- Life after Stillbirth
- The possible impact of COVID 19 on fertility and ART
- Human embryonic stem cell–derived blastocyst-like spheroids resemble human trophectoderm during early implantation process
- What support is available for you in hospital if you lose your baby
- The role of total chromosomal disomy in human spermatozoa as a predictor of the outcome of pre-implantation genetic screening
Be First to Comment